User menu

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.

Bibliographic reference NGO-GIANG-HUONG, N ; WITTKOP, L ; REISS, P ; GOETGHEBUER, T ; DUICULESCU, D ; et. al. Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.. In: BMC Infectious Diseases, Vol. Nov 8, no.16, p. 654 (2016)
Permanent URL http://hdl.handle.net/2078.1/181676
  1. Geretti Anna Maria, Epidemiology of antiretroviral drug resistance in drug-naïve persons : , 10.1097/qco.0b013e328013caff
  2. Goodman Derrick D, Zhou Yun, Margot Nicolas A, McColl Damian J, Zhong Lijie, Borroto-Esoda Katyna, Miller Michael D, Svarovskaia Evguenia S, Low level of the K103N HIV-1 above a threshold is associated with virological failure in treatment-naive individuals undergoing efavirenz-containing therapy : , 10.1097/qad.0b013e3283427dcb
  3. Kantor Rami, Smeaton Laura, Vardhanabhuti Saran, Hudelson Sarah E., Wallis Carol L., Tripathy Srikanth, Morgado Mariza G., Saravanan Shanmugham, Balakrishnan Pachamuthu, Reitsma Marissa, Hart Stephen, Mellors John W., Halvas Elias, Grinsztejn Beatriz, Hosseinipour Mina C., Kumwenda Johnstone, La Rosa Alberto, Lalloo Umesh G., Lama Javier R., Rassool Mohammed, Santos Breno R., Supparatpinyo Khuanchai, Hakim James, Flanigan Timothy, Kumarasamy Nagalingeswaran, Campbell Thomas B., Eshleman Susan H., Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial, 10.1093/cid/civ102
  4. Kuritzkes Daniel R., Lalama Christina M., Ribaudo Heather J., Marcial Michelle, Meyer III William A., Shikuma Cecilia, Johnson Victoria A., Fiscus Susan A., D’Aquila Richard T., Schackman Bruce R., Acosta Edward P., Gulick Roy M., Preexisting Resistance to Nonnucleoside Reverse‐Transcriptase Inhibitors Predicts Virologic Failure of an Efavirenz‐Based Regimen in Treatment‐Naive HIV‐1–Infected Subjects, 10.1086/528802
  5. Paredes R, Lalama CM, Ribaudo HJ, Schackman BR, Shikuma C, Giguel F, Meyer 3rd WA, Johnson VA, Fiscus SA, D’Aquila RT, et al. Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure. J Infect Dis. 2010;201(5):662–71.
  6. Wittkop Linda, Günthard Huldrych F, de Wolf Frank, Dunn David, Cozzi-Lepri Alessandro, de Luca Andrea, Kücherer Claudia, Obel Niels, von Wyl Viktor, Masquelier Bernard, Stephan Christoph, Torti Carlo, Antinori Andrea, García Federico, Judd Ali, Porter Kholoud, Thiébaut Rodolphe, Castro Hannah, van Sighem Ard I, Colin Céline, Kjaer Jesper, Lundgren Jens D, Paredes Roger, Pozniak Anton, Clotet Bonaventura, Phillips Andrew, Pillay Deenan, Chêne Geneviève, Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study, 10.1016/s1473-3099(11)70032-9
  7. Zeh Clement, Weidle Paul J., Nafisa Lillian, Lwamba Humphrey M., Okonji Jully, Anyango Emily, Bondo Philip, Masaba Rose, Fowler Mary Glenn, Nkengasong John N., Thigpen Michael C., Thomas Timothy, HIV-1 Drug Resistance Emergence among Breastfeeding Infants Born to HIV-Infected Mothers during a Single-Arm Trial of Triple-Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission: A Secondary Analysis, 10.1371/journal.pmed.1000430
  8. Eshleman Susan H., Mracna Martin, Guay Laura A., Deseyve Martina, Cunningham Shawn, Mirochnick Mark, Musoke Philippa, Fleming Thomas, Fowler Mary Glenn, Mofenson Lynne M., Mmiro Francis, Jackson J. Brooks, Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012) : , 10.1097/00002030-200110190-00006
  9. Martinson Neil A, Morris Lynn, Gray Glenda, Moodley Daya, Pillay Visva, Cohen Sarah, Dhlamini Puleng, Puren Adrian, Bhayroo Schene, Steyn Jan, McIntyre James A, Selection and Persistence of Viral Resistance in HIV-Infected Children After Exposure to Single-Dose Nevirapine : , 10.1097/qai.0b013e31802b920e
  10. Masquelier Bernard, Chaix Marie-Laure, Burgard Marianne, Lechenadec Jérome, Doussin Anne, Simon François, Cottalorda Jacqueline, Izopet Jacques, Tamalet Catherine, Douard Danielle, Fleury Hervé, Mayaux Marie-Jeanne, Blanche Stéphane, Rouzioux Christine, Zidovudine Genotypic Resistance in HIV-1–Infected Newborns in the French Perinatal Cohort : , 10.1097/00126334-200106010-00001
  11. Lockman Shahin, Shapiro Roger L., Smeaton Laura M., Wester Carolyn, Thior Ibou, Stevens Lisa, Chand Fatima, Makhema Joseph, Moffat Claire, Asmelash Aida, Ndase Patrick, Arimi Peter, van Widenfelt Erik, Mazhani Loeto, Novitsky Vladimir, Lagakos Stephen, Essex Max, Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine, 10.1056/nejmoa062876
  12. Hunt Gillian M., Coovadia Ashraf, Abrams Elaine J., Sherman Gayle, Meyers Tammy, Morris Lynn, Kuhn Louise, HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine : , 10.1097/qad.0b013e3283492180
  13. Lehman Dara A., Wamalwa Dalton C., McCoy Connor O., Matsen Frederick A., Langat Agnes, Chohan Bhavna H., Benki-Nugent Sarah, Custers-Allen Rebecca, Bushman Frederic D., John-Stewart Grace C., Overbaugh Julie, Low-Frequency Nevirapine Resistance at Multiple Sites May Predict Treatment Failure in Infants on Nevirapine-Based Treatment : , 10.1097/qai.0b013e3182515730
  14. MacLeod Iain J., Rowley Christopher F., Thior Ibou, Wester Carolyn, Makhema Joseph, Essex Max, Lockman Shahin, Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART, 10.1016/j.jcv.2010.03.017
  15. Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Available at https://aidsinfo.nih.gov/contentfiles/lvguidelines/pediatricguidelines.pdf . Accessed 16 Apr 2015. [Clinical and Laboratory Monitoring of Children with HIV Infection, Entry into Care—Baseline Evaluation: D-4]. Update March 5, 2015.
  16. Bamford A, Turkova A, Lyall H, Foster C, Klein N, Bastiaans D, Burger D, Bernadi S, Butler K, Chiappini E, Clayden P, Della Negra M, Giacomet V, Giaquinto C, Gibb D, Galli L, Hainaut M, Koros M, Marques L, Nastouli E, Niehues T, Noguera-Julian A, Rojo P, Rudin C, Scherpbier HJ, Tudor-Williams G, Welch SB, , Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life : PENTA 2015 paediatric HIV-1 treatment guidelines, 10.1111/hiv.12217
  17. Fokam Joseph, Salpini Romina, Santoro Maria Mercedes, Cento Valeria, Perno Carlo-Federico, Colizzi Vittorio, Ndumbe Peter Martins, Fokunang Ntungen Charles, Ndiang Tetang Suzie Moyo, Nanfack Aubin Joseph, Takou Komego Désiré Augustin, Cappelli Giulia, Drug Resistance Among Drug-naive and First-line Antiretroviral Treatment-failing Children in Cameroon : , 10.1097/inf.0b013e31822db54c
  18. Neogi Ujjwal, Sahoo Pravat Nalini, De Costa Ayesha, Shet Anita, High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naïve perinatally-infected children and adolescents with HIV-1 subtype C infection, 10.1186/1471-2334-12-317
  19. Gupta Ravindra K, Jordan Michael R, Sultan Binta J, Hill Andrew, Davis Daniel HJ, Gregson John, Sawyer Anthony W, Hamers Raph L, Ndembi Nicaise, Pillay Deenan, Bertagnolio Silvia, Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis, 10.1016/s0140-6736(12)61038-1
  20. Hamers Raph L, Wallis Carole L, Kityo Cissy, Siwale Margaret, Mandaliya Kishor, Conradie Francesca, Botes Mariette E, Wellington Maureen, Osibogun Akin, Sigaloff Kim C E, Nankya Immaculate, Schuurman Rob, Wit Ferdinand W, Stevens Wendy S, van Vugt Michèle, de Wit Tobias F Rinke, HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study, 10.1016/s1473-3099(11)70149-9
  21. Parker Monica M., Wade Nancy, Lloyd, Robert M., Birkhead Guthrie S., Gallagher Brian K., Cheku Babu, Sullivan Timothy, Taylor Jill, Prevalence of Genotypic Drug Resistance Among a Cohort of HIV-Infected Newborns : , 10.1097/00126334-200303010-00008
  22. Perez L, Correa C, Campos YA, Gonzalez I, Perez J, Martinez PA, Alvarez A, Soto Y, Kouri V. Drug-resistant HIV-1 in Cuban children and their seropositive mothers. MEDICC Rev. 2011;13(2):24–31.
  23. Rojas Sánchez Patricia, Holguín Africa, Drug resistance in the HIV-1-infected paediatric population worldwide: a systematic review, 10.1093/jac/dku104
  24. Simonetti SRR, Schatzmayr HG, Simonetti JP, Human immunodeficiency virus type 1: drug resistance in treated and untreated Brazilian children, 10.1590/s0074-02762003000600021
  25. Soto-Ramirez Luis E., Rodriguez-Diaz Roberto, Harris D. Robert, Hazra Rohan, HIV Drug Resistance-Associated Mutations in Antiretroviral Naïve HIV-1-Infected Latin American Children, 10.1155/2010/407476
  26. Kjaer J, Ledergerber B. HIV cohort collaborations: proposal for harmonization of data exchange. Antivir Ther. 2004;9(4):631–3.
  27. Aebi-Popp K., Mulcahy F., Rudin C., Hoesli I., Gingelmaier A., Lyons F., Thorne C., National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ?, 10.1093/eurpub/ckt028
  28. British HIV Association. Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV BHIVA Pregnancy guidelines – March 2005. http://www.bhiva.org/documents/Guidelines/Pregnancy/2005/2005PregGL.pdf . Accessed 24 Mar 2016.
  29. Salzberger B, Marcus U, Vielhaber B, Arasteh K, Golz J, Brockmeyer NH, Rockstroh J. German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004). Eur J Med Res. 2004;9(11):491–504.
  30. Iribarren José Antonio, Labarga Pablo, Rubio Rafael, Berenguer Juan, Miró José M, Antela Antonio, González Juan, Moreno Santiago, Arrizabalaga Julio, Chamorro Lourdes, Clotet Bonaventura, Gatell José M, López-Aldeguer José, Martínez Esteban, Polo Rosa, Tuset Montserrat, Viciana Pompeyo, Santamaría Juan Miguel, Kindelán José María, Ribera Esteve, Segura Ferrán, Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en pacientes adultos infectados por el VIH (octubre 2004), 10.1157/13069520
  31. Iribarren José A., Ramos José T., Guerra Luis, Coll Oriol, Isabel de José María, Domingo Pere, Fortuny Claudia, Miralles Pilar, Parras Francisco, Peña José María, Rodrigo Carlos, Vidal Ricard, Prevención de la transmisión vertical y tratamiento de la infección por el virus de la inmunodeficiencia humana en la mujer embarazada, 10.1016/s0213-005x(01)72652-3
  32. Voramongkol N, Naiwatanakul T, Punsuwan N, Kullerk N, Lolekha R, Sarika P, Pattarakulwanich S, McConnell MS. Compliance with and outcomes of CD4-based national guidelines for prevention of mother-to-child transmission of HIV for Thailand, 2006–2007. Southeast Asian J Trop Med Public Health. 2013;44(6):997–1009.
  33. Bennett Diane E., Camacho Ricardo J., Otelea Dan, Kuritzkes Daniel R., Fleury Hervé, Kiuchi Mark, Heneine Walid, Kantor Rami, Jordan Michael R., Schapiro Jonathan M., Vandamme Anne-Mieke, Sandstrom Paul, Boucher Charles A. B., van de Vijver David, Rhee Soo-Yon, Liu Tommy F., Pillay Deenan, Shafer Robert W., Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update, 10.1371/journal.pone.0004724
  34. Liu T. F., Shafer R. W., Web Resources for HIV Type 1 Genotypic-Resistance Test Interpretation, 10.1086/503914
  35. Schoenfeld David A., Sample-Size Formula for the Proportional-Hazards Regression Model, 10.2307/2531021
  36. Flys Tamara S., McConnell Michelle S., Matovu Flavia, Church Jessica D., Bagenda Danstan, Khaki Leila, Bakaki Paul, Thigpen Michael C., Eure Chineta, Fowler Mary Glenn, Eshleman Susan H., Nevirapine Resistance in Women and Infants after First versus Repeated Use of Single‐Dose Nevirapine for Prevention of HIV‐1 Vertical Transmission, 10.1086/590160
  37. Fisher Randall G., Smith Davey M., Murrell Ben, Slabbert Ruhan, Kirby Bronwyn M., Edson Clair, Cotton Mark F., Haubrich Richard H., Kosakovsky Pond Sergei L., Van Zyl Gert U., Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure, 10.1016/j.jcv.2014.11.014
  38. Bunupuradah Torsak, Puthanakit Thanyawee, Kosalaraksa Pope, Kerr Stephen, Boonrak Pitch, Prasitsuebsai Wasana, Lumbiganon Pagakrong, Mengthaisong Tawan, Phasomsap Chayapa, Pancharoen Chitsanu, Ruxrungtham Kiat, Ananworanich Jintanat, Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children, 10.1186/1742-6405-8-40
  39. Bunupuradah Torsak, Sricharoenchai Sirintip, Hansudewechakul Rawiwan, Klinbuayaem Virat, Teeraananchai Sirinya, Wittawatmongkol Orasri, Akarathum Noppadon, Prasithsirikul Wisit, Ananworanich Jintanat, Risk of First-line Antiretroviral Therapy Failure in HIV-infected Thai Children and Adolescents : , 10.1097/inf.0000000000000584
  40. Charpentier Charlotte, Gody Jean-Chrysostome, Mbitikon Olivia, Moussa Sandrine, Matta Mathieu, Péré Hélène, Fournier Julien, Longo Jean De Dieu, Bélec Laurent, Virological Response and Resistance Profiles After 18 to 30 Months of First- or Second-/Third-Line Antiretroviral Treatment: A Cross-Sectional Evaluation in HIV Type 1-Infected Children Living in the Central African Republic, 10.1089/aid.2011.0035
  41. Jittamala Podjanee, Puthanakit Thanyawee, Chaiinseeard Sukrapee, Sirisanthana Virat, Predictors of Virologic Failure and Genotypic Resistance Mutation Patterns in Thai Children Receiving Non-Nucleoside Reverse Transcriptase Inhibitor–Based Antiretroviral Therapy : , 10.1097/inf.0b013e3181a458f9
  42. Pham HV, Ishizaki A, Nguyen LV, Phan CTT, Phung TTB, Takemoto K, Pham AN, Bi X, Khu DTK, Ichimura H, Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam, 10.1177/0956462414556328
  43. Palumbo Paul, Lindsey Jane C., Hughes Michael D., Cotton Mark F., Bobat Raziya, Meyers Tammy, Bwakura-Dangarembizi Mutsawashe, Chi Benjamin H., Musoke Philippa, Kamthunzi Portia, Schimana Werner, Purdue Lynette, Eshleman Susan H., Abrams Elaine J., Millar Linda, Petzold Elizabeth, Mofenson Lynne M., Jean-Philippe Patrick, Violari Avy, Antiretroviral Treatment for Children with Peripartum Nevirapine Exposure, 10.1056/nejmoa1000931
  44. Violari Avy, Lindsey Jane C., Hughes Michael D., Mujuru Hilda A., Barlow-Mosha Linda, Kamthunzi Portia, Chi Benjamin H., Cotton Mark F., Moultrie Harry, Khadse Sandhya, Schimana Werner, Bobat Raziya, Purdue Lynette, Eshleman Susan H., Abrams Elaine J., Millar Linda, Petzold Elizabeth, Mofenson Lynne M., Jean-Philippe Patrick, Palumbo Paul, Nevirapine versus Ritonavir-Boosted Lopinavir for HIV-Infected Children, 10.1056/nejmoa1113249
  45. Lowenthal Elizabeth D., Ellenberg Jonas H., Machine Edwin, Sagdeo Aditi, Boiditswe Sefelani, Steenhoff Andrew P., Rutstein Richard, Anabwani Gabriel, Gross Robert, Association Between Efavirenz-Based Compared With Nevirapine-Based Antiretroviral Regimens and Virological Failure in HIV-Infected Children, 10.1001/jama.2013.3710
  46. Penazzato M, Prendergast A, Tierney J, Cotton M, Gibb D. Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age. Cochrane Database Syst Rev. 2012;7:CD004772.
  47. Sebunya Robert, Musiime Victor, Kitaka Sabrina, Ndeezi Grace, Incidence and risk factors for first line anti retroviral treatment failure among Ugandan children attending an urban HIV clinic, 10.1186/1742-6405-10-25
  48. Highly active antiretroviral therapy started in infants under 3 months of age : 72-week follow-up for CD4 cell count, viral load and drug resistance outcome, 10.1097/00002030-200401230-00013
  49. LITALIEN CATHERINE, FAYE ALBERT, COMPAGNUCCI ALEXANDRA, GIAQUINTO CARLO, HARPER LYNDA, GIBB DIANA M., JACQZ-AIGRAIN EVELYNE, Pharmacokinetics of nelfinavir and its active metabolite, hydroxy-tert-butylamide, in infants perinatally infected with human immunodeficiency virus type 1 : , 10.1097/00006454-200301000-00014
  50. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach June 2013.  http://www.who.int/hiv/pub/guidelines/arv2013/en/ . Accessed 27 Oct 2016.
  51. Davies Mary-Ann, Boulle Andrew, Fakir Tanzeem, Nuttall James, Eley Brian, Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study, 10.1186/1471-2431-8-34
  52. GIBB DIANA M., GOODALL RUTH L., GIACOMET VANIA, MCGEE LAURA, COMPAGNUCCI ALEX, LYALL HERMIONE, Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial : , 10.1097/00006454-200301000-00015
  53. REDDINGTON CATHERINE, COHEN JOYCE, BALDILLO ARLENE, TOYE MARIPAT, SMITH DOROTHY, KNEUT CATHERINE, DEMARIA ALFRED, BERTOLLI JEANNE, HSU HO-WEN, Adherence to medication regimens among children with human immunodeficiency virus infection : , 10.1097/00006454-200012000-00005
  54. Van Dyke R. B., Lee S., Johnson G. M., Wiznia A., Mohan K., Stanley K., Morse E. V., Krogstad P. A., Nachman S., Reported Adherence as a Determinant of Response to Highly Active Antiretroviral Therapy in Children Who Have Human Immunodeficiency Virus Infection, 10.1542/peds.109.4.e61
  55. Lange Camille Marie, Hué Stéphane, Violari Avy, Cotton Mark, Gibb Diana, Babiker Abdel, Otwombe Kennedy, Panchia Ravindre, Dobbels Els, Jean-Philippe Patrick, McIntyre James A., Pillay Deenan, Gupta Ravindra Kumar, Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy : , 10.1097/qai.0000000000000568